Daily News Podcast

Opioids don’t top NSAIDs for chronic pain


 

Opioids’ pain relief and physical function benefits don’t top NSAIDs in chronic noncancer pain. A barbershop-based hypertension intervention is still going strong a year later. Canakinumab has a remarkable effect on knee and hip replacement risk. And low-tech BMI compares favorably with body scanning for cardiometabolic screening.

Amazon Alexa

Apple Podcasts

Google Podcasts

Spotify

Recommended Reading

Is fibromyalgia one disorder – or two?
MDedge Cardiology
Antibody cleared amyloid plaques, slowed cognitive decline
MDedge Cardiology
Diclofenac’s cardiovascular risk confirmed in novel Nordic study
MDedge Cardiology
Colonoscopy: Should 45 be the new 50?
MDedge Cardiology
Sprain an ankle, get an opioid
MDedge Cardiology
Physician burnout singes patient safety
MDedge Cardiology
Does America have a gabapentinoid problem?
MDedge Cardiology
Short-term NSAIDs appear safe for high-risk patients
MDedge Cardiology
Palliative care update highlights role of nonspecialists
MDedge Cardiology
Insulin loses its starting spot
MDedge Cardiology